Search 

Biotech and Money is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion dollar healthcare businesses.

We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.

New technologies have the potential to transform healthcare and medical research by increasing efficiency and creating more personalised medicine.

Ctrl Group is a team of designers, researchers, software developers and healthcare experts who work internationally with healthcare companies and providers who want to use new technology to improve people’s health. We create products and services that are effective, engaging and safe.

Datatrial is a clinical biometrics and technology organization specializing in complete study delivery; from our flexible and intuitive platform of technologies to our services and consulting. We offer a full range of services including Data Management, Statistics and Medical Writing. 

With headquarters in Newcastle upon Tyne, UK and offices in Boston MA and BioHub at Alderley Park, UK we are very able to support global clinical development programs. Since 1999, we have been serving the pharmaceutical community through our commitment to service and quality in every aspect of the work that we do. With involvement in over 300 clinical trials, across 25 therapeutic areas and with extensive oncology experience we will work with you to develop a study plan that best fits your needs. 

Our innovative nowEDC™ solution will allow you to deliver data capture, verification and validation, query management, data extract, IWRS and real-time reporting in one integrated system. nowEDC is easy-to-use, fully validated and is highly configurable. The flexible aspects of nowEDC also make it a natural fit for handling both complex trial designs as well as adaptive clinical trials. We are a service-driven company; our customers and the clinical development programmes that we support are important to us. 

Our goal is to meet timelines, exceed expectations through our proactive approach, and be responsive to and collaborative with our customers. Communication, service and quality are critical to a successful clinical study, while always keeping the patient in mind.

ERA Consulting has served the biopharmaceutical industry for over 28 years, providing regulatory, strategic and technical guidance for the development of medicinal agents (>450 to date), including gene and cell therapies, recombinant protein/antibody therapeutics, vaccines and small molecules.

Our specialised international team of 32 full-time professionals includes consultants from biotech, pharma, biomanufacturing, regulatory and academic scientific backgrounds to provide experienced support from product inception through development to commercialisation.

First Derivatives occupies a niche position within the market place offering a combination domain knowledge of financial markets and expertise in financial services technologies. We provide innovative trading platforms for low latency, high volume environments across all asset classes including FX, equity, fixed income and commodities - providing credit, market, operational, liquidity, capital adequacy and stress testing solutions. The Company scopes, designs, develops, implements and supports a broad range of mission critical data and trading systems across front, middle and back-office operations.

IDACO supports academics, TTOs, start-ups, SMEs and corporate organisations looking for R&D support, outsourcing options and partnering opportunities. 

Services Offered:

•       Strategic pharmaceutical and pre-clinical consulting services.

•       Due diligence, evaluation and de-risking of R&D.

•       Advice and support on out-sourcing strategies - looking for timely and cost-effective solutions.

•       Scouting the academic network to identify new opportunities for pharmaceutical and medical device companies.

•       Business development support for organisations wanting to access the academic, outsourcing or commercial networks.

•       Oversight and project management of outsourced CMC and preclinical projects.

Mirador Analytics is an analytics and consultancy firm providing drug commercialization assessment and launch planning services to biopharma organizations around the world. We are a UK and North American-based firm with extensive expertise in: Asset Evaluation; Pricing and Market Access; Asset and Portfolio Prioritization; KOL Mapping; Market and Competitor Intelligence; Market Research; Insight and Analytics; Medical and Regulatory Affairs; Business Development; and Commercialization Planning.

Mirador Analytics is unique in their combined analytical and consultancy offering. In contrast to other analytical organizations, our combined analytical and consultancy services enable us to bring industry-specific relevance to our clients’ analytical and data-driven needs. Mirador Analytics' team members have all worked on our clients’ side of the business, allowing us to fully appreciate the intricacies of the pharmaceutical sector and our clients’ specific requirements. Similarly, and in contrast to other consultancy organizations, our proprietary analytical tools provide the analytical rigor that is vital to our clients’ commercialization requirements.

We can support our clients with the use of our proprietary prevalence-based Asset Evaluation Tool and Individual Identification Database (I.I.D), along with our extensive consultancy services. With your internal data and insights, along with external data, we apply our extensive experience and knowledge to generate clear outputs that are relevant to you and your organization.

Mirador Analytics’ Wraparound Services:
Mirador Analytics offers a complete wraparound service built around our analytical tools. Our extensive expertise in the pharmaceutical sector enables us to support you with data inputs, assumptions and output interpretations. From developing payer frameworks and target product profiles to competitive landscape reviews, the Mirador Analytics’ team has the international experience to assist your organization in achieving its strategic objectives. Our expertise spans across Medical Affairs; Pricing and Market Access; Insight and Analytics; Strategy; Marketing; and Business Development. Our working relationship with you is built upon collaboration; we work closely with you at each stage of the project and remain mindful of your specific requirements. In working with Mirador Analytics, you can expect the delivery of outputs that are data driven, relevant, and supported by analytical rigour and insights from team members who have sat on your side of the business.

• Experience in how your organization functions, with team members who have worked on your side of the business.
• Integrated services to better serve the needs of your organization.
• The knowledge to generate clear outputs, which are relevant to you and your organization, using a combination of your internal company data and external data sources.
• Valuing collaboration – we have an ability to listen and highly encourage client input at every stage of our journey together.

PHASTAR is a specialist CRO offering statistical consultancy, clinical trial reporting (including data management) and medical writing services, by providing expert consultants and delivering in-house projects.

Every project PHASTAR undertakes is supervised on methodology and utilises internal processes designed to ensure optimal quality. We are headquartered in London with 7 offices globally across four continents, and the largest statistical CRO group in Europe.

Sciad Communications is a leading marketing and PR consultancy working in Health, Science and Tech.Our aim is to make our clients more successful. By integrating Brand, PR and Digital Marketing we build reputations, accelerate growth and attract investment. We have an excellent track record in developing communications programmes for our clients, helping them to stay ahead of their competitors and become market leaders.